Cholesteryl ester transfer protein inhibition: a pathway to reducing risk of morbidity and promoting longevity.
Abstract
To review the evidence and describe the biological plausibility for the benefits of inhibiting cholesteryl ester transfer protein (CETP) on multiple organ systems through modification of lipoprotein metabolism.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper discusses the inhibition of cholesteryl ester transfer protein (CETP) and its potential benefits on multiple organ systems through the modification of lipoprotein metabolism. This suggests a focus on a biological pathway that could influence aging processes and longevity. However, the impact appears to be limited as it primarily reviews existing evidence rather than presenting novel findings or significant advancements in the field.
Author of this paper? Send a correction.